PlainRecalls
FDA Drug Moderate Class II Ongoing

Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.

Reported: August 27, 2025 Initiated: August 4, 2025 #D-0590-2025

Product Description

Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.

Reason for Recall

Lack of Assurance of Sterility.

Details

Recalling Firm
PFIZER INC
Units Affected
49,620 vials
Distribution
U.S. Nationwide
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.. Recalled by PFIZER INC. Units affected: 49,620 vials.
Why was this product recalled?
Lack of Assurance of Sterility.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 27, 2025. Severity: Moderate. Recall number: D-0590-2025.